×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Shame and Blame: Our Words are a Barrier to Clinical Research are a Care Option
Session Chair(s)
Lani Hashimoto
Associate Director, Patient Engagement
Novartis Pharmaceuticals Corporation, United States
Clinical research creates future clinical care. Let's lead in compassionate communication inviting more participation. Patient, site, and patient-focused drug development (PFDD) experts share and invite your participation in improving access through our words.
Learning Objective : Identify the shame and blame negative words and phrases and their negative impact on patients; Recognize opportunities to improve the patient experience in clinical research as a care option through more compassionate word choice; Describe how to plan and justify optimization of protocol, informed consent, and participant communication language.
Speaker(s)
Panelist
Jamie Troil Goldfarb
Trialbee, United States
Director, Patient Recruitment Strategy
Panelist
Eddilisa Martin
M&B Sciences Inc., United States
Co-Founder and Chief Executive Officer
Panelist
James Duhig, PhD
AbbVie, United States
Global Head, Office of Health Literacy
Have an account?